Putin Presides Over Russia’s Victory Day Parade Without Tanks
In Moscow, a scaled-back Victory Day parade marked by the absence of tanks and missiles. Markets react as analysts we...
Year Long Money Challenges
Consider year long money challenges to maintain consistent savings throughout the year. Commit to your financial goals today!
27,082 articlesXRP Price Outlook: Will 2026 Bring a Breakout for Traders?
XRP trades near $1.50 in mid-May 2026 as traders weigh a potential move to $3 this year. Regulatory clarity and liqui...
Guggenheim Just Slapped Rating on StubHub: Buy Target at $12.50
Guggenheim started coverage on StubHub with a Buy rating and a $12.50 price target, signaling optimism for the live-e...
Every Analyst Watching Wrong AI Stock: The One That Matters
The AI boom often centers on GPUs and big models, but the true mover is the network that ties data and compute togeth...
Auto (LI) 2026 Earnings Outlook for Li Auto Investors
Li Auto's 2026 earnings outlook hinges on shipments, margins, and smart capital allocation. This deep dive breaks dow...
The Only Public Space Stock Elon Musk Cannot Dismiss
Rocket Lab stands as the only public space stock with a direct line to actual launches and defense demand, even as Sp...
Price Prediction: DKNG Stock Closer to a 2026 Breakout
DraftKings is under renewed scrutiny as it rolls out Predictions and posts a mixed Q1 2026. Our price prediction: dkn...
Federal Reserve Just Delivered Bad News for Republicans
The Fed has signaled rates may stay elevated for longer, stressing household budgets and complicating campaign messag...
Intel Today: Outperforming Other Chip Makers Sparks Rally
Intel surged about 8% in midday trading, topping gains among the mega-cap chip names. The move comes as investors wei...
Chip Index’s Climb Giving Fund Managers the Heebie-Jeebies
As the chip index climbs, fund managers sit on a cautious chair, weighing gains against risk. Bank of America flags p...
AppLovin Could $600+ with AI Ad-Tech Rebound: Stock Outlook
AppLovin is rebounding as AI ad-tech momentum returns, with analysts modeling upside to $600+ as AXON 2 expands and b...
Can’t Stop Buying This Dividend Juggernaut: ABBV Growth
A long-time investor explains why AbbVie’s mix of rapidly growing immunology drugs and a dependable dividend keeps dr...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status